A study the safety and effects of ARA 290 administered subcutaneously on pain relief in patients with chronic pain from complex regional pain syndrome type 1.
- Registry ID
- EUCTR2012-003688-24
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE2
- Sponsor
- Leiden University Medical Center
- Start date
- 2012-09-18
- Last update
- 2026-08-16
Conditions
- Complex regional pain syndrome
Summary
To assess the safety, and ability of subcutaneously administered ARA 290 to reduce pain, assessed by Numerical Rating Score of "pain now" and Global Health self-assessment, during and after 4 weeks of treatment with ARA 290 or placebo
Locations
View on source registry